Mesenchymal stem cells (MSCs) have been extensively investigated for the treatment of
various diseases. The therapeutic potential of MSCs is attributed to complex cellular and …

Type 1 and type 2 diabetes mellitus is a serious and lifelong condition commonly
characterised by abnormally elevated blood glucose levels due to a failure in insulin …

Adipose tissue is now on the top one of stem cell sources regarding its accessibility,
abundance, and less painful collection procedure when compared to other sources. The …

The unique immunomodulatory properties of mesenchymal stem cells (MSCs) make them
an invaluable cell type for the repair of tissue/organ damage caused by chronic inflammation …

Mortality from hepatitis B virus (HBV)–related acute‐on‐chronic liver failure (ACLF) is high
due to limited treatment options. Preclinical and clinical investigations have proved that …

Since its introduction more than twenty years ago, intraportal allogeneic cadaveric islet
transplantation has been shown to be a promising therapy for patients with Type I Diabetes …

The pleiotropic behavior of mesenchymal stem cells (MSCs) has gained global attention due
to their immense potential for immunosuppression and their therapeutic role in immune …

Introduction The ability to self-renew, be easily expanded in vitro and differentiate into
different mesenchymal tissues, render mesenchymal stem cells (MSCs) an attractive …

Infusion of mesenchymal stem cells (MSCs) has been shown to effectively lower blood
glucose in diabetic individuals, but the mechanism involved could not be adequately …

Mesenchymal stem cells (MSCs) are adult stem cells that can be isolated from most adult
tissues, including bone marrow, adipose, liver, amniotic fluid, lung, skeletal muscle and …